Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives $39.86 Consensus Target Price from Brokerages
Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) has earned a consensus recommendation of “Buy” from the nine research firms that are currently covering the company, Marketbeat.com reports. Seven equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average twelve-month price […]
Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) has earned a consensus recommendation of “Buy” from the nine research firms that are currently covering the company, Marketbeat.com reports. Seven equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average twelve-month price […]
